Munich Personal RePEc Archive
metadata only
Property Rights on Biodiversity and the Pharmaceutical Industry
Major pharmaceutical companies such as Smith Kline Beecham, Merck, Glaxo and Lilly, and a score of smaller ones, are developing profitable business opportunities in the world's forest while preserving biodiversity and producing incentives for leaving the forests intact. This case study covers the bu
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Business models for biodiversity#352120
- Regulatory Malfunctions in the Drug Patent Ecosystem#352172
- Biodiversity and the Patent System: Towards International Indicators#163551
- 16 U.S.C. § 482p — Patents affecting lands within forest#570437
- The Willows General Management Ltd v Hawkins (Rev1)(PARK HOMES - PITCH FEE REVIEW - validity of notices - notice not given by site owner) [2026] UKUT 263 (LC) (13 July 2026)#366161
Record · ID 1277978
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive